On November 5, 2025, the 8th China International Import Expo (hereinafter referred to as “CIIE”) grandly opened at the National Exhibition and Convention Center (Shanghai). As the world’s first national-level expo themed on imports, this year’s CIIE brought together innovative products from around the world, setting a new record for scale. It attracted participation from 155 countries, regions, and international organizations, with 4,108 overseas companies exhibiting, becoming a global focus. On the first day of the expo, Chief Executive of the Hong Kong Special Administrative Region, John Lee, led a delegation from the Hong Kong SAR Government to visit the Hong Kong exhibition area. Jia Xiaojia, CEO and co-founder of Eieling Technology, highlighted the company’s latest product in the field of liver health, the FattaLab® Liver Fat Analyzer, to Chief Executive Lee, and presented him with a FattaLab® mass-produced model HK0001! The Chief Executive highly praised the innovative design and technological value of FattaLab®.
As an innovative company focusing on liver health, Eieling Technology showcased its flagship products, the Liverscan® Quantitative Shear Wave Ultrasonic Liver Analyzer and the FattaLab® Liver Fat Analyzer, at the China International Import Expo (CIIE), comprehensively demonstrating its leading solutions in liver health screening and management, which attracted widespread attention from experts and visitors at the event.
During the visit, Jia Xiaojia, CEO of Eieling Technology, gave the delegation a detailed introduction to the company’s latest achievements in the field of liver health management. He stated that Eieling Technology, relying on the research foundation of Hong Kong Polytechnic University, continues to deeply cultivate the field of liver disease diagnosis and treatment, adhering to original research and innovation, promoting product iteration and upgrades, and is committed to providing better solutions for liver disease patients worldwide. Currently, Liverscan® has been put into clinical use in medical institutions in mainland China, Hong Kong, Macau, Southeast Asia, North America, South America, the Middle East, Africa, and other countries and regions. Chief Executive Lee Ka-chiu carefully examined FattaLab®, listened to the company’s research progress and global market layout development, and fully affirmed the technological achievements and product innovations exhibited by Eieling Technology.
It is worth mentioning that FattaLab® Global Superfactory, established by Eieling Technology in Jiangning District, Nanjing, will help Nanjing become Eieling Technology’s second benchmark city for liver disease screening globally. E-Link Technology is continuously strengthening its strategic deployment of core technologies and product resources and is fully committed to promoting the company’s high-quality development.
Continuing to deepen innovation and helping Hong Kong’s innovation and technology achieve new breakthroughs
Chief Executive John Lee highly praised E-Link Technology’s innovative strength and development potential, encouraging the company to continue its technological research and development, help Hong Kong achieve new breakthroughs in innovation and technology, and contribute more to improving people’s health. Eieling Technology CEO Jia Xiaojia expressed her gratitude for the Chief Executive’s encouragement and support, and pledged that the company will fully utilize Hong Kong’s international platform advantages, continuously increase R&D investment, and leverage international platforms such as the China International Import Expo to promote more leading technological solutions globally, contributing to the innovation and technology development of Hong Kong and the nation.
Chief Executive John Lee’s visit fully demonstrates the Hong Kong SAR Government’s high regard for technology innovation enterprises. As a leader in Hong Kong’s science and technology innovation, Eieling Technology is showcasing the innovative charm and limitless possibilities of Chinese enterprises to the world with its solid innovative achievements and global vision.